Bad Neighborhood: Fibrotic Stroma as a New Player in Melanoma Resistance to Targeted Therapies

Current treatments for metastatic cutaneous melanoma include immunotherapies and drugs targeting key molecules of the mitogen-activated protein kinase (MAPK) pathway, which is often activated by BRAF driver mutations. Overall responses from patients with metastatic BRAF mutant melanoma are better wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Diazzi, Serena, Tartare-Deckert, Sophie, Deckert, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352197/
https://www.ncbi.nlm.nih.gov/pubmed/32466585
http://dx.doi.org/10.3390/cancers12061364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352197/
https://www.ncbi.nlm.nih.gov/pubmed/32466585
http://dx.doi.org/10.3390/cancers12061364

Ejemplares similares